97260 ⎘
Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
VHH for application in tissue repair, organ regeneration, organ replacement and tissue engineering
#602Oligopeptide and methods for producing conjugates thereof
#603Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#604Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
#605Compositions and methods to modulate cell activity
#606Baff selective binding compounds and related methods
#607Methods for the preparation of compounds directed against interleukin-6 receptor (IL-6R)
#608SECRETION AND FUNCTIONAL DISPLAY OF CHIMERIC POLYPEPTIDES
#609ANTIGEN BINDING POLYPEPTIDES
#610Plexin D1 as a target for tumor diagnosis and therapy
#611Amino acid sequences that modulate the interaction between cells of the immune system
#612Pulmonary administration of immunoglobulin single variable domains and constructs thereof
#613Amino acid sequences that modulate the interaction between cells of the immune system
#614Method for inhibiting the immune suppressive function of human T regulatory cells by administering an anti-GARP monoclonal antibody
#615Chemokine receptor binding polypeptides
#616Synergistic combinations of OX40L antibodies for the treatment of GVHD
#617Binding-triggered transcriptional switches and methods of use thereof
#618Method for generation of immunoglobulin sequences
#619Formulations of single domain antigen binding molecules
#620Synthetic single domain antibody
#621ANTIBODIES TO COMPLEX TARGETS
#622Immobilized Single Domain Antigen-Binding Molecules
#623Compositions and methods for increasing protein half-life in a serum
#624Targeting of human interferon antagonists
#625Targeted modified IL-1 family members
#626Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
#627CAMELID SINGLE HEAVY-CHAIN ANTIBODY DIRECTED AGAINST CHROMATIN AND USES OF SAME
#628AGROCHEMICAL COMPOSITIONS COMPRISING ANTIBODIES BINDING TO SPHINGOLIPIDS
#629Methylation and acetylation sites
#630Anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer
#631ANTIBODY DISPLAY
#632Chimeras of lumazine synthase and beta subunit of ABtoxins
#633Single domain antibodies against SOD1 and their use in medicine
#634Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use
#635Stable formulations of immunoglobulin single variable domains
#636Fusion proteins and immunoconjugates and uses thereof which are specific for glycophorin A
#637Production of antibody formats and immunological applications of said formats
#638Agrochemical compositions comprising antibodies binding to sphingolipids
#639Recombinant polypeptide production
#640Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain
#641METHOD FOR AFFINITY PURIFICATION
#642METHOD FOR ENGINEERING IMMUNOGLOBULINS
#643Anti c-Met antibodies
#644Anti c-Met antibodies
#645Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies
#646Anti-semaphorin 3A antibody and treatment of Alzheimer's disease and inflammatory immune diseases using same
#647Targeting and in vivo imaging of tumor-associated macrophages
#648Single-domain antigen-binding proteins that bind mammalian IgG
#649Biological materials related to c-Met
#650Anti-campylobacter jejuni antibodies and uses therefor
#651Amino acid sequences directed against cellular receptors for viruses and bacteria
#652Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
#653Recognition tags for TGase-mediated conjugation
#654Bispecific HER2 ligands for cancer therapy
#655Bi-specific affinity reagents for cell-lineage-specific TNF-alpha neutralization
#656Designer Ubiquitin Ligases for Regulation of Intracellular Pathogenic Proteins
#657Antibodies to CD70
#658Antigen binding polypeptides
#659Protective anti-ETEC antibody
#660Antigen binding polypeptides
#661Antigen binding polypeptides
#662Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides
#663Protease-based biosensor
#664Single variable domain antibodies against OX40L, constructs and therapeutic use
#665Enhancement of transport of therapeutic molecules across the blood brain barrier
#666ANTIBODIES COMPRISING SEQUENCES FROM CAMELIDAE TO HIGHLY CONSERVED TARGETS
#667Method for purifying transgenic factor VII/VIIA
#668Highly diverse combinatorial antibody libraries
#669IL-6 binding molecules
#670P2X7 receptor antagonists and agonists
#671Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
#672Biological materials related to CXCR7
#673Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
#674Protein constructs designed for targeting and lysis of cells
#675Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
#676Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
#677Sortase-modified VHH domains and uses thereof
#678Single domain antibodies capable of modulating BACE activity
#679STABILIZED SINGLE DOMAIN ANTIBODIES
#680Humanized antibodies
#681Methods for treating rheumatoid arthritis by administering interleukin-6 receptor antibodies
#682Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
#683Methods of using IL-6R antibodies to block or reduce binding of IL-6 to IL-6R
#684Single domain antibodies as inhibitors of PCSK9
#685Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the treatment of cancers and/or tumors
#686Nucleic acids that encode interleukin-6 receptor binding polypeptides
#687Methods for blocking or reducing binding of interleukin-6 to interleukin-6 receptor
#688Anti IL-6R polypeptides and compositions thereof
#689Biological materials related to c-Met
#690Nanobodies against tumor necrosis factor-alpha
#691Nanoantibodies, binding antigen, method for inhibition of infection induced by
#692Nucleic acids encoding IL-6R-binding polypeptides
#693Lung-targeting nanobodies against pulmonary surfactant protein A and their preparation
#694Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using same
#695Influenza virus antibody compositions
#696Biological materials related to c-Met
#697Chimeric human-llama antigens and methods of use
#698Binding domains directed against GPCR:G protein complexes and uses derived thereof
#699Anti-VCAM-1 nanobodies
#700Antibodies to CD70
#701Serum albumin binding proteins
#702Interleukin-6 receptor binding polypeptides
#703PROLONGED INHIBITION OF INTERLEUKIN-6 MEDIATED SIGNALING
#704Anti c-Met antibodies
#705Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#706Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
#707TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#708Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
#709Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, composition, and treatment methods for rotavirus infections
#710Biological materials related to CXCR7
#711Stable formulations of polypeptides and uses thereof
#712Inhibition of bone resorption with RANKL binding peptides
#713Antibodies to CD70
#714Method for the production of immunoglobulin single variable domains
#715Antibodies to CD70
#716Method for producing solid formulations comprising immunoglobulin single variable domains
#717MMP8 inactivating antigen binding proteins
#718Antigen binding formats for use in therapeutic treatments or diagnostic assays
#719A-beta binding polypeptides
#720Binding molecules
#721Binding molecules
#722Antigen-binding protein directed against epitope in the CH1 domain of human IgG antibodies
#723Chemokine receptor binding polypeptides
#724Single-domain antibodies that bind to HIV-1 Nef with high affinity
#725Soluble heavy-chain only antibodies
#726Anti-CEACAM6 antibodies and uses thereof
#727Anti-cobra toxin antibody fragments and method of producing a VH library
#728-specific antibodies and uses thereof
#729Chitinous polysaccharide antigen-binding proteins
#730Compositions for seed treatment
#731CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
#732Library-based methods and compositions for introducing molecular switch functionality into protein affinity reagents
#733Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#734Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
#735Binding domain-immunoglobulin fusion proteins
#736Biological materials related to HER3
#737Pulmonary administration of immunoglobulin single variable domains and constructs thereof
#738Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
#739Bispecific binding molecules binding to VEGF and ANG2
#740Anti-ICAM-1 single domain antibody and uses thereof
#741COMPOSITIONS AND METHODS FOR IMPROVING PRODUCTION OF RECOMBINANT POLYPEPTIDES
#742Single variable domain antibodies against OX40L, constructs and therapeutic use
#743Nucleic acid molecules encoding A-beta binding polypeptides
#744DELIVERY OF IMMUNOGLOBULIN VARIABLE DOMAINS AND CONSTRUCTS THEREOF
#745Plexin D1 as a target for tumor diagnosis and therapy
#746Antibody humanization by framework assembly
#747Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
#748Targeting and in vivo imaging of tumor-associated macrophages
#749SINGLE CHAIN ANTIBODIES FOR PHOTOSYNTHETIC MICROORGANISMS AND METHODS OF USE
#750VHH for application in tissue repair, organ regeneration, organ replacement and tissue engineering
#751Anti-Botulinum Neurotoxin a Single Domain Antibody Antibodies
#752BIPARATOPIC PROTEIN CONSTRUCTS DIRECTED AGAINST IL-23
#753PEPTIDES CAPABLE OF BINDING TO SERUM PROTEINS AND COMPOUNDS, CONSTRUCTS AND POLYPEPTIDES COMPRISING THE SAME
#754STABILIZED SINGLE DOMAIN ANTIBODIES
#755Biological materials related to c-Met
#756VEGF-BINDING MOLECULES
#757STABLE FORMULATIONS OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND USES THEREOF
#758Binding domain-immunoglobulin fusion proteins
#759SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
#760Screening of protein candidates
#761FUNCTIONAL HEAVY CHAIN ANTIBODIES, FRAGMENTS THEREOF, LIBRARY THEREOF AND METHODS OF PRODUCTION THEREOF
#762Nanobody against IL-6R
#763C-Met antibody combinations
#764Soluble “heavy-chain only” antibodies
#765Detection and visualization of the cell cycle in living cells
#766Anti c-Met antibodies
#767Heavy Chain and Domain Antibodies
#768Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
#769Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
#770Anti-IL-6R polypeptides and pharmaceutical compositions thereof
#771Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
#772Antigen binding polypeptides
#773Mixtures of binding proteins
#774A-beta binding polypeptides
#775Formulations targeting IGFBP7 for diagnosis and therapy of cancer
#776BINDING MOLECULES WITH MULTIPLE BINDING SITES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
#777Anti-cobra toxin antibody fragments and method of producing a VH library
#778Biologic compounds directed against death receptor 5
#779Amino acid sequences directed against cellular receptors for viruses and bacteria
#780PULMONARY ADMINISTRATION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND CONSTRUCTS THEREOF
#781Antigen binding polypeptides
#782AMINO ACID SEQUENCES DIRECTED AGAINST INTEGRINS AND USES THEREOF
#783Amino acid sequences directed against multitarget scavenger receptors and polypeptides
#784AMINO ACID SEQUENCES DIRECTED AGAINST GROWTH FACTOR RECEPTORS AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH GROWTH FACTORS AND THEIR RECEPTORS
#785Biological materials related to CXCR7
#786AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM
#787Selective targeting of intratumoral cells
#788IMMUNOGLOBULINS DEVOID OF LIGHT CHAINS
#789FUNCTIONAL HEAVY CHAIN ANTIBODIES, FRAGMENTS THEREOF, LIBRARY THEREOF AND METHODS OF PRODUCTION THEREOF
#790Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
#791PEPTIDES CAPABLE OF BINDING TO SERUM PROTEINS AND COMPOUNDS, CONSTRUCTS AND POLYPEPTIDES COMPRISING THE SAME
#792BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS
#793Composition for targeting dendritic cells
#794Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
#795VHH ANTIBODY FRAGMENTS FOR USE IN THE DETECTION AND TREATMENT OF CANCER
#796DLL4-BINGING MOLECULES
#797IMMUNOGLOBULIN CONSTRUCTS
#798Combination of CD137 antibody and CTLA-4 antibody for the treatment of proliferative diseases
#799SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR
#800SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
#801METHOD OF ADMINISTERING THERAPEUTIC POLYPEPTIDES, AND POLYPEPTIDES THEREFOR
#802METHODS TO STABILIZE PROTEINS AND POLYPEPTIDES
#803Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
#804STABILIZED SINGLE DOMAIN ANTIBODIES
#805BISPECIFIC BINDING MOLECULES FOR ANTI-ANGIOGENESIS THERAPY
#806Single domain brain-targeting antibody fragments derived from llama antibodies
#807Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases
#808Humanized antibodies
#809BINDING MOLECULES WITH MULTIPLE BINDING SITES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
#810Compositions Comprising Antibodies or Antibody Fragments
#811SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR
#812BINDING MOLECULES
#813AMINO ACID SEQUENCES DIRECTED AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF CONDITIONS AND DISEASES CHARACTERIZED BY EXCESSIVE AND/OR PATHOLOGICAL ANGIOGENESIS OR NEOVASCULARIZATION
#814IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN DIRECTED AGAINST HUMAN CXCR4 AND OTHER CELL ASSOCIATED PROTEINS AND METHODS TO GENERATE THEM
#815Single variable domains against notch pathway members
#816Binding domain-immunoglobulin fusion proteins
#817BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF
#818NOVEL ANTIGEN BINDING DIMER-COMPLEXES, METHODS OF MAKING AND USES THEREOF
#819Binding domain-immunoglobulin fusion proteins
#820Single domain antibodies capable of modulating BACE activity
#821Process for producing Apo2L
#822Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
#823Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
#824AMINO ACID SEQUENCES DIRECTED AGAINST HETERODIMERIC CYTOKINES AND/OR THEIR RECEPTORS AND POLYPEPTIDES COMPRISING THE SAME
#825NON-AGGREGATING HUMAN VH DOMAINS
#826MULTIFUNCTIONAL LINKER PROTEIN CONTAINING AN ANTIBODY AGAINST HEMAGGLUTININ, A CONSERVED INFLUENZA ANTIGEN AND AN IMMUNOSTIMULATING CARRIER BINDING DOMAIN
#827METHOD FOR OBTAINING POLYPEPTIDE CONSTRUCTS COMPRISING TWO OR MORE SINGLE DOMAIN ANTIBODIES
#828SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
#829Method for the production of a single heavy chain antibody
#830Method for the production of a single heavy chain antibody
#831Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#832Single domain VHH antibodies against Von Willebrand Factor
#833Antigen binding polypeptides
#834Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
#835Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein Aggregates
#836Single-domain antigen-binding proteins that bind mammalian IgG
#837Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
#838BINDING CONSTRUCTS AND METHODS FOR USE THEREOF
#839Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins
#840ANTI-AMYLOID ANTIBODIES AND THEIR USE IN DIAGNOSIS AND THERAPY OF AMYLOID DISEASES
#841USE OF A CAMELID SINGLE-DOMAIN ANTIBODY FOR DETECTING AN OLIGOMERIC FORM OF AN AMYLOID BETA PEPTIDE AND ITS APPLICATIONS
#842METHODS AND MOLECULES FOR MODULATING AN IMMUNE RESPONSE
#843COMPOSITIONS AND METHODS FOR IMPROVING PRODUCTION OF RECOMBINANT POLYPEPTIDES
#844MEDICAL DELIVERY DEVICE FOR THERAPEUTIC PROTEINS BASED ON SINGLE DOMAIN ANTIBODIES
#845Binding molecules
#846AMINO ACID SEQUENCES THAT BIND TO A DESIRED MOLECULE IN A CONDITIONAL MANNER
#847Interleukin-6 receptor binding polypeptides
#848BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS
#849Binding molecules
#850Method for generation of immunoglobulin sequences
#851ZINC OXIDE-BINDING ANTIBODY AND USE THEREOF
#852ORAL DELIVERY OF POLYPEPTIDES
#853Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
#854Formulations of single domain antigen binding molecules
#855METHODS FOR USING ANTIBODIES AND ANALOGS THEREOF
#856Anti-FC-receptor single domain antibodies (nanobodies-tm) and therapeutic use
#857Isolation and purification of antibodies using protein A affinity chromatography
#858AMINO ACID SEQUENCES DIRECTED AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF CONDITIONS AND DISEASES CHARACTERIZED BY EXCESSIVE AND/OR PATHOLOGICAL ANGIOGENESIS OR NEOVASCULARIZATION
#859Systems, methods and microrganisms for antibody production with type III secretion system
#860PLEXIN D1 AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY
#861Serum albumin binding proteins with long half-lives
#862Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#863ANTIBODIES, ANALOGS AND USES THEREOF
#864Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
#865POLYPEPTIDE CONSTRUCTS FOR SUBLINGUAL ADMINISTRATION
#866Binding domain-immunoglobulin fusion proteins
#867Eliminating unreachable subscribers in voice-over-ip networks
#868Method for engineering immunoglobulins
#869Polypeptides that modulate the interaction between cells of the immune system
#870Single domain VHH antibodies against von Willebrand factor
#871Polypeptide constructs including VHH directed against EGFR for intracellular delivery
#872VHH antibodies used as peptide vectors for delivering a substance of interest
#873SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR
#874POLYPEPTIDE CONSTRUCTS FOR TOPICAL ADMINISTRATION
#875POLYPEPTIDE CONSTRUCTS FOR RECTAL AND/OR VAGINAL ADMINISTRATION
#876Anti-apoptotic protein antibodies
#877POLYPEPTIDE CONSTRUCTS FOR NASAL ADMINISTRATION
#878Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling
#879DP-78-Like Nanobodies
#880Binding molecules
#881Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
#882Nanobodies and Polypeptides Against EGFR and IGF-IR
#883Stabilized single domain antibodies
#884Targeted Delivery of Compounds Using Multimerization Technology
#885Modified aerolysin and methods of use for treating lung cancer
#886Food Products Comprising Probiotic Micro-Organisms and Antibodies
#887Target substance capturing molecule
#888Production of antibody formats and immunological applications of said formats
#889BINDING CONSTRUCTS AND METHODS FOR USE THEREOF
#890Composition
#891Bispecific capturing molecule
#892BINDING MOLECULES
#893Single-domain brain-targeting antibody fragments derived from LLAMA antibodies
#894TARGETING AND TRACING OF ANTIGENS IN LIVING CELLS
#895Compositions comprising modified biologically active polypeptides
#896BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF
#897Serum albumin binding proteins
#898Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
#899V-Like Domain Binding Molecules
#900Protein constructs designed for targeting and lysis of cells